This article highlights key takeaways from the Harvard International Forum on Autism Science and Families, from the perspective of children with autism. At this event, children with autism were no longer seen as peripheral—they became the very center of attention, embraced with understanding, warmth, and respect. No longer were they distant lights; they were radiant, supported stars.

This article summarizes the most compelling insights from the “Harvard International Forum on Autism Science and Family,” focusing specifically on the role of families. It aims to bridge scientific research with real-world family needs, offering practical perspectives and takeaways for families living with autism.

Torskal SAS, a French oncology innovator developing non-ionizing plasmonic PTT for cancers, has partnered with Houston-based SaniMed as its fundraising and strategic business consultant for US and international markets. SaniMed’s expertise in life science investments and commercialization will drive Torskal’s expansion and clinical development. The alliance accelerates breakthrough treatment advancements.

SaniMed Science Group offers U.S. high school and college students unique internships in medical innovation, business, and finance. Interns gain real-world experience, expert mentorship, and global exposure while enhancing leadership, communication, and professional skills—preparing them for competitive careers in the healthcare and tech-driven business sectors.

This article presents a systematic academic summary of the key themes and expert discussions from the “Harvard International Forum on Autism Science and Family,” with a focus on cutting-edge research, innovative approaches, and the broader social impact of autism studies.